Taking into account the relevance of HE4 and CA125 in the diagnosis of ovarian cancer, we investigated the levels of these two tumor markers in the SARS-CoV-2 group compared to the ovarian cancer patients (OC) (Group 4). This evidence concerns the gene WFDC2 and ovarian carcinoma.